Pyrls on Instagram: Brexpiprazole's (REXULTI) new indication makes it the first FDA-approved option for agitation associated with dementia due to Alzheimer's disease ✨ Learn more about brexpiprazole in your Pyrls app or

292 likes, 1 comments - pyrls no May 14, 2023: "Brexpiprazole's (REXULTI) new indication makes it the first FDA-approved option for agitation ass"

Rexulti On Track To Add Claim For Alzheimer's Dementia Agitation Following US Panel Nod :: Pink Sheet

FDA Approves the First Drug for Alzheimer's Agitation: Rexulti

SLU Researcher Finds Help for Alzheimer's-Associated Agitation with New FDA- Approved Treatment : SLU

First-Ever Drug for Alzheimer's Agitation, Brexpiprazole, Nears Finish Line

These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for Agitation - Mad In America

Your Guide to FDA-Approved Alzheimer's Drugs